Secukinumab Clinical Trials in Nanjing, Jiangsu
3 recruitingNanjing, Jiangsu, China
Showing 1–3 of 3 trials
Recruiting
A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
Psoriasis (PsO)Psoriasis ArthritisSecukinumab+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School50 enrolled2 locationsNCT06987292
Recruiting
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)SecukinumabHidradenitis Suppurativa (Acne Inversa)
Peking Union Medical College100 enrolled1 locationNCT06926192
Recruiting
Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
Psoriatic ArthritisUltrasonographySecukinumab
Nanjing Medical University400 enrolled2 locationsNCT06730334